PanGen Biotech Inc (222110) — Cash Flow Quality Index

Latest as of September 2025: -6.88x

PanGen Biotech Inc (222110) has a Cash Flow Quality Index of -6.88x as of September 2025. Operating cash flow of ₩-3.66 Billion is below net income of ₩531.94 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore PanGen Biotech Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-6.88x

Operating CF / Net Income

Operating Cash Flow

₩-3.66 Billion

KRW

Net Income

₩531.94 Million

KRW

Data as of

Sep 2025

Most recent filing

PanGen Biotech Inc Cash Flow Quality Index (2024–2024)

Historical Cash Flow Quality Index for PanGen Biotech Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 222110 cash flow metrics.

Annual Cash Flow Quality Index for PanGen Biotech Inc (2024–2024)

Year-by-year earnings quality comparison for PanGen Biotech Inc.

Year	Quality Index	Operating CF (KRW)	Net Income	YoY Change
2024	3.17x	₩2.99 Billion	₩943.69 Million	—

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.